The Valley Desk

NCT03740529 · Interventional trial

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Overall registry status Completed

Phase 1 · Phase 2

Conditions B-cell Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov